4Front Ventures Corp.
FFNTFDelisted- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001783875
4Front Ventures Corp. was delisted in 2026; its insiders filed their last Form 4 on May 19, 2025; no institution reported holding it in 13F filings for Q2 2026; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in 4Front Ventures Corp. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 2
- +1 vs. Q2 2022
- Shares held
- 121.5K
- +71.5K (+143.0%) vs. Q2 2022
- Total value
- $40.0K
- +$12.0K (+42.9%) vs. Q2 2022
- New holders
- 1
- 1 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FFNTF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $4.20K |
| Q4 2023 | 1 | $6.68K |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $6.24K |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 1 | $23.0K |
| Q3 2022 | 2 | $40.0K |
| Q2 2022 | 1 | $28.0K |
| Q1 2022 | 3 | $1.60M |
| Q4 2021 | 3 | $2.03M |
| Q3 2021 | 2 | $95.0K |
| Q2 2021 | 3 | $117.9K |
| Q1 2021 | 2 | $108.0K |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding 4Front Ventures Corp.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Gofen & Glossberg LLC | 88,500 | $29.0K | 0.00% | +38,500+77.0% | Added |
| Dearborn Partners LLC | 33,000 | $11.0K | 0.00% | +33,000 | New |